HF Daily Papers
· Papers
Beyond Drug Discovery: The Nanotechnology Molecular Optimization (NMO) Benchmark
Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets. This combination yields strong benchmark metrics but limits transferability to domains structurally distinct from drug discovery. To overcome this limitat